Evidence map›Paper›PMID 39414601›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Chinese expert consensus on the diagnosis and management of elderly patients with follicular lymphoma (2024)].

Hematology Oncology Committee of China Anti-Cancer Association, Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association, Chinese Working Group of Follicular Lymphoma, Society of Hematology, Chinese Geriatrics Society, Lymphoma Expert Committee of Chinese Anti-cancer Association, Lymphoma Expert Committee of Chinese Aging Well Association

Abstract readConsensus StatementEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hematology Oncology Committee of China Anti-Cancer Association
Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association
Chinese Working Group of Follicular Lymphoma
Society of Hematology, Chinese Geriatrics Society
Lymphoma Expert Committee of Chinese Anti-cancer Association
Lymphoma Expert Committee of Chinese Aging Well Association

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the general population of China, the number of older patients with follicular lymphoma (FL) will continue to increase with age. The treatment of elderly patients with FL is based on individual principles, which focuses on the improvement of tumor-related symptoms and quality of life. To improve the diagnosis and treatment of elderly patients with FL in China, several organizations (i.e., Hematology Oncology Committee of China Anti-Cancer Association, etc.) have gathered relevant experts to formulate this consensus.

Indexed as

Lymphoma, FollicularAgedChinaConsensusHumansQuality of Life

Identifiers

PMID39414601
PMCPMC11518910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.